About ELEGEN
Elegen was founded in 2017 in San Carlos, CA. We work in biotechnology, combining synthetic biology, DNA synthesis, microfluidics, hardware, engineering, organic chemistry, and molecular biology. We develop technologies for DNA writing.
Our main product, ENFINIA™ DNA Synthesis, is a cell-free platform that produces DNA sequences up to 7 kb with error rates as low as 1:70,000/bp. We manufacture our products in the USA, verify them with NGS, and ship globally. Our patented ENFINIA™ DNA platform uses microfluidics, AI, and robotics to deliver long, high-quality, high-complexity DNA.
The ENFINIA GEN II Production Platform offers high-throughput DNA production for as little as $0.07/bp. It uses less space and generates less waste than cell-based cloning methods. Our technology helps accelerate mRNA therapeutics development and cell-free protein synthesis.
We are also developing the GEN II oligosynthesizer, planned for 2026. This will be a directed-split-pool microfluidic synthesizer with integrated cell-free cloning technology.
We aim to address bottlenecks in synthetic biology for pharmaceutical, biotechnology, agribusiness, and biomanufacturing customers. Dr. Matthew Hill is our founder and CEO. Investors include Andreessen Horowitz, 8VC, and KdT.
Mission & Values
Our mission is to reprogram biology to create solutions for global challenges.
We focus on improving DNA manufacturing to support the growing bioeconomy. This allows synthetic biology developers to avoid expensive, time-consuming, and capital-intensive steps by providing fast, accurate, complex, and long synthetic DNA.
Our culture values mutual respect, integrity, and collaboration.
Team & Culture
We are a fast-paced, impactful startup with a multidisciplinary team.
Our culture is built on mutual respect, integrity, and collaboration.
Benefits & Perks
We offer healthcare, dental, vision, a learning allowance, 401K, flexible PTO, short-term disability, a fitness allowance, long-term disability, a parental leave program, and commuter benefits.
Frequently Asked Questions
Elegen offers ENFINIA™ DNA Synthesis, an entirely cell-free platform for producing DNA sequences up to 7 kb with high accuracy. This includes the ENFINIA GEN II Production Platform for high-throughput DNA synthesis and the upcoming GEN II oligosynthesizer. Their products are used in applications such as mRNA therapeutics development and cell-free protein synthesis.
Elegen’s culture is built on mutual respect, integrity, and collaboration. The company aims to support the bioeconomy by providing innovative, fast-turnaround, high-accuracy, and complex synthetic DNA solutions to address challenges in synthetic biology.
Elegen provides healthcare, dental, vision, a learning allowance, 401K, flexible PTO, short term disability, a fitness allowance, long term disability, a parental leave program, and commuter benefits.
Elegen uses a patented, entirely cell-free DNA synthesis platform, ENFINIA™, which integrates microfluidics, AI, and robotics. This technology is designed to deliver long, clonal quality, high complexity, and double-stranded DNA products with speed and efficiency, reducing the reliance on traditional cell-based cloning methods.
ELEGEN was founded in 2017.
ELEGEN is active in the Microfluidics, Hardware, Synthetic Biology, Engineering, Organic Chemsitry, Dna Synthesis, Molecular Biology, and Biology markets.
ELEGEN has 51-200 employees.
ELEGEN hires globally with a remote-first approach, allowing employees to work from anywhere.
ELEGEN is not actively hiring at the moment. Check back later for new opportunities.
Yes, ELEGEN is a remote-first company.
ELEGEN's website is www.elegenbio.com .
You can find ELEGEN on X (Twitter) and LinkedIn .
Remote companies like ELEGEN
Find your next opportunity with companies that specialize in Microfluidics, Hardware, Synthetic Biology, and Engineering. Explore remote-first companies like ELEGEN that prioritize flexible work and home-office freedom.
Maravai LifeSciences
Providing nucleic acid products, enzyme development, and biologics safety testing for life sciences companies.
Molecular Assemblies, Inc.
Enzymatic DNA synthesis for long, high-quality, sequence-specific DNA.
GenScript
Services and products for biotech and healthcare research, focusing on gene, peptide, protein, and antibody solutions.
Ultima Genomics
Developing DNA sequencing platforms for high-throughput, cost-effective genomic information.
Project: Career Search
Rev. 2026.2
[ Remote Jobs ]
Direct Access
We source jobs directly from 21,000+ company career pages. No intermediaries.
Discover Hidden Jobs
Unique jobs you won't find on other job boards.
Advanced Filters
Filter by category, benefits, seniority, and more.
Priority Job Alerts
Get timely alerts for new job openings every day.
Manage Your Job Hunt
Save jobs you like and keep a simple list of your applications.